These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30310283)

  • 1. Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery.
    Zariwala MG; Bendre H; Markiv A; Farnaud S; Renshaw D; Taylor KM; Somavarapu S
    Int J Nanomedicine; 2018; 13():5837-5848. PubMed ID: 30310283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxifloxacin loaded nanoparticles of disulfide bridged thiolated chitosan-eudragit RS100 for controlled drug delivery.
    Iqbal O; Shah S; Abbas G; Rasul A; Hanif M; Ashfaq M; Afzal Z
    Int J Biol Macromol; 2021 Jul; 182():2087-2096. PubMed ID: 34087298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, optimization and characterization of bovine lactoferrin-loaded liposomes and solid lipid particles modified by hydrophilic polymers using factorial design.
    Yao X; Bunt C; Cornish J; Quek SY; Wen J
    Chem Biol Drug Des; 2014 May; 83(5):560-75. PubMed ID: 24325576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization, cytotoxicity and drug release behavior of liposome-enveloped paclitaxel/Fe3O4 nanoparticles.
    Kim MJ; Jang DH; Lee YI; Jung HS; Lee HJ; Choa YH
    J Nanosci Nanotechnol; 2011 Jan; 11(1):889-93. PubMed ID: 21446568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery.
    Wang F; Yang Y; Ju X; Udenigwe CC; He R
    J Agric Food Chem; 2018 Mar; 66(11):2685-2693. PubMed ID: 29451796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.
    Han HK; Shin HJ; Ha DH
    Eur J Pharm Sci; 2012 Aug; 46(5):500-7. PubMed ID: 22522117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel approach to oral iron delivery using ferrous sulphate loaded solid lipid nanoparticles.
    Zariwala MG; Elsaid N; Jackson TL; Corral López F; Farnaud S; Somavarapu S; Renshaw D
    Int J Pharm; 2013 Nov; 456(2):400-7. PubMed ID: 24012860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascorbyl palmitate/DSPE-PEG nanocarriers for oral iron delivery: preparation, characterisation and in vitro evaluation.
    Zariwala MG; Farnaud S; Merchant Z; Somavarapu S; Renshaw D
    Colloids Surf B Biointerfaces; 2014 Mar; 115():86-92. PubMed ID: 24333557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation.
    Saremi S; Atyabi F; Akhlaghi SP; Ostad SN; Dinarvand R
    Int J Nanomedicine; 2011 Jan; 6():119-28. PubMed ID: 21289989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
    Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.
    Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y
    Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
    Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosan.
    Chiu YL; Ho YC; Chen YM; Peng SF; Ke CJ; Chen KJ; Mi FL; Sung HW
    J Control Release; 2010 Aug; 146(1):152-9. PubMed ID: 20580915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR; Sharma CP
    J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrophobic amino acids grafted onto chitosan: a novel amphiphilic chitosan nanocarrier for hydrophobic drugs.
    Motiei M; Kashanian S; Taherpour AA
    Drug Dev Ind Pharm; 2017 Jan; 43(1):1-11. PubMed ID: 27802776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of 3,6-O,O'- dimyristoyl chitosan micelles for oral delivery of paclitaxel.
    Silva DS; Almeida A; Prezotti F; Cury B; Campana-Filho SP; Sarmento B
    Colloids Surf B Biointerfaces; 2017 Apr; 152():220-228. PubMed ID: 28113124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrophobic lapatinib encapsulated dextran-chitosan nanoparticles using a toxic solvent free method: fabrication, release property & in vitro anti-cancer activity.
    Mobasseri R; Karimi M; Tian L; Naderi-Manesh H; Ramakrishna S
    Mater Sci Eng C Mater Biol Appl; 2017 May; 74():413-421. PubMed ID: 28254312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
    Shinde UA; Joshi PN; Jain DD; Singh K
    Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
    Takeuchi H; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
    Int J Pharm; 2005 Oct; 303(1-2):160-70. PubMed ID: 16125348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.